–
TRAINING
All of the ESRs recruited by PET3D will be exposed to a variety of highly complementary research environments spanning different therapeutic areas: oncology, cardiovascular, neuroscience and all of the ESRs will spend at least one secondment in a different country and will have the opportunity to attend training events and consortium meetings in all of the 7 countries involved in PET3D.
–
LOCAL TRAINING

Each ESR will be exposed to the following:
- Cutting edge research training, technical training, generic skills training.
- Cross-sectorial training – translational skills training, commercialisation.
- Access to state of the art technologies in each of the beneficiary sites.
- Transferrable and generic skills training – communications, presentation, writing, management, dissemination, intellectual property rights protection, dissemination and exploitation, ethical issues, entrepreneurial initiatives, CV writing and interview training available locally at each beneficiary site.
- Strong collaborative bonds with each ESR, with supervisors and mentors and also with researchers in related fields, thereby laying the foundation for future continued European-wide research collaboration.
–
SECONDMENTS
ESR1 - Host ABD
Secondment
AZ, May 2018, for 6 months,
For in vitro and ex-vivo profiling, and pharmacokinetic studies on 3H/14C versions of fatty acid analogues and CPT1 inhibitors.
ESR2 - Host ABD
Secondment
AMS, month 30, for 3 months,
‘for exploring full antibody or nanobody versions of the tracer.
ESR3 - Host AMS
Secondments
1. BER, month 9, for 3 months,
for design and synthesis of target compounds.
2. IMA, month 18, for 6 months,
for performing chemistry and animal studies, development of complementary skills (e.g. business, project management).
ESR4 - Host AMD
Secondments
1. ABD, month 26, for 6 months,
for evaluation of clearing agent on in vivo behaviour proteins and peptides.
2. BRU, month 33, for 2 months,
for comparing BRU’s nanobody technology products to come to best practice.
ESR5 - Host BRU
Secondments
1. ABD, month 7, for 4 months
to gain knowledge on 18F-FDR radiochemistry
2. IMA, month 24, for 6 months,
for GMP production, toxicity study, IMPD writing, training on IP.
ESR6 - Host BRU
Secondment
AZ, November 2018, for 6 months,
translational pre-clinical studies on radioisotope- and NIR-labelled nanobodies.
ESR7 - Host SAN
Secondments
1. ABD, May 2018, for 4 months,
to gain knowledge on pre-targeting strategies and related synthetic chemistry.
2. IMA, June 2019, for 4 months,
to acquire skills in image quantification and kinetic modeling.
ESR8 - Host SAN
Secondments
1. BRU, month 16, for 2 months,
to gain knowledge on nanobody technology.
2. AZ, month 28, for 6 months,
to bind an oncology compound from AstraZeneca to the NanoBite platform.
ESR9 - Host BER
Secondment
AZ, month 18, for 6 months,
for biodistribution studies through micro-dosing and drug validation studies.
ESR10 - Host BER
Secondment
IMA, month 29, for 6 months
for performing biodistribution studies and metabolite characterisation.
ESR11 - Host MUN
Secondment
IMA, month 12, for 6 months
to study therapeutic modulation of neuroinflammation via pre-clinical PET imaging.
ESR12 - Host MUN
Secondment
AZ, month 6, for 6 months
to study best modality of therapeutic intervention (e.g. anti-angiogenesis).
ESR13 - Host ABD
Secondment
AMS, month 24, for 6 months
for performing PET imaging studies on pre-targeted click tracers.
ESR14 - Host IMA
Secondments
1. BER, month 13, for 3 months
for studying a pre-targeted approach to hypoxia PET imaging.
2. MUN, month 25, for 3 months
for exploring a pre-targeted PET imaging approach to gliomas.
3. ICL, month 8 and month 20 for 2 months each
characterisation of the constructs.
ESR15 - Host AZ
Secondment
ABD, September 2018, for 6 months
to develop a [18F]-labeled tracer and perform pre-clinical studies in vivo.
–
NETWORK WIDE
In addition to local training, this ETN offers cutting-edge Network-wide training opportunities, see overview in ‘Main Network Training Events & Conferences’.
Dissemination events are public conferences or symposia on:
- hot scientific topics of interest to PET3D
- transferrable skills/employability workshops
- business-related events
These events will be of particular interest to radiopharmaceuticals/drug discovery stakeholders and students.

Schools are larger and structured training initiatives lasting from 2 days to 5 days.
Activity | Structure | Month/Duration/Location/ECTS | Main Organisers/lecturers |
School in Radiopharmaceutical development | • 10 lectures of 2hr • 3 days experimental • Written exam | Month 7 / 5 days Amsterdam/ 2.5 ECTS | Prof. A.D. Windhorst (Chair and organiser), Dr D.J. Vugts, Prof G.A.M.S. van Dongen |
School in Radiopharmaceuticals in Drug Discovery | • 6 lectures of 2 hr • Overview of Drug discovery & development process • Tour of site & exemplary drug discovery project | Month 13 /2 days AstraZeneca site Mölndal / 1 ECTS | Chair and Organiser: Dr. C. S. Elmore (AZ); Lecturers: Dr. J. Passchier (IMA). Lectures from Advisory Board members |
School in Nanobody Theranostics | • Intensive program on molecular imaging with • 9 Lectures and • Hands-on practical training • Round table discussion | Month 25/ 4 days / Brussels/ 2 ECTS | Chair and Organiser: Prof. V. Caveliers (BRU). Lecturers: Dr. T. Lahoutte (BRU), Dr. N. Devoogdt (BRU), Dr. M. R. Zalutsky (Duke University, USA), Dr. V. Caveliers (BRU), Dr. C. Xavier (BRU), Dr. S. Hernot (BRU), Dr. S. Muyldermans (BRU). |
School in Pre-clinical imaging | • In-depth training on state-of-the-art molecular imaging with • 6 plenary lectures of 2 hr and • 7 hands-on sessions on a broad spectrum of dedicated imaging technologies including μPET, μSPECT, μCT, μMRI, and optical imaging. | Month 36/ 5 days/ Muenster/ 2.5 ECTS | Chair and Organiser: Prof. A. Jacobs (MUN) |
Training events are smaller, 1-day training courses/workshops, which will be open to external participants and therefore will also represent dissemination opportunities.
Activity | Structure / Content | Month/Duration/Location/ECTS | Speakers |
Training Workshop in “European Regulatory Aspects in Radiopharmaceuticals” | • 6 hr training event • 4 talks • Open to public • 15 external attendees planned | Month 19 / 1 day Bergen / 0.5 ECTS | (Prof. AD Windhorst, AMS); (Dr. J. Passchier, IMA); (Dr. D. Graham, ABD). Plus invited external speaker |
Training Workshop in “Integrating PET imaging in drug development: a market model for PET imaging” | • 6 hr training event • 6 talks • Open to public • 25 external attendees planned | Month 25 /1 day Brussels / 0.5 ECTS | (Prof. A. Murray, ABD); (Dr. C. Elmore, AZ) (Prof. GAMS van Dongen, AMS). Plus invited external speakers |
Training Workshop in “Complementary and Transferable Skills for Scientists” | • 8 hr training event • 7 talks • Research ethics and bioethics; Scientific peer communication; Writing grant applications; Communicating science to the public and the role of media; Life after PET3D: how to make the most of your CV; IP management and its importance to researchers; Science and business: how to create a “biotech” (or other) company. • Business lunch to discuss student employability • Open to public • 20 external attendees planned | Month 31 / 1 day / San Sebastian/ 0.5 ECTS | Prof. M. Zanda (ABD, co-founder of KemoTech, www.kemotech.it) Seven external speakers will be invited, plus Advisory Board member. |